Glenmede Trust’s Agilysys AGYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Sell
3,532
-1,986
-36% -$154K ﹤0.01% 1093
2026
Q1
$393K Buy
5,518
+165
+3% +$14.3K ﹤0.01% 1053
2025
Q4
$636K Buy
+5,353
New +$644K ﹤0.01% 868
2025
Q1
$314K Buy
4,327
+2,084
+93% +$190K ﹤0.01% 1070
2024
Q4
$295K Buy
2,243
+249
+12% +$30.5K ﹤0.01% 1104
2024
Q3
$217K Buy
+1,994
New +$213K ﹤0.01% 1206
2020
Q4
Sell
-196
Closed -$4K 1216
2020
Q3
$4K Buy
196
+56
+40% +$1.25K ﹤0.01% 2118
2020
Q2
$2K Buy
140
+103
+278% +$1.93K ﹤0.01% 2212
2020
Q1
$0 Hold
37
﹤0.01% 2999
2019
Q4
$0 Hold
37
﹤0.01% 3002
2019
Q3
$0 Buy
+37
New +$941 ﹤0.01% 3001

Other funds holding AGYS

Glenmede Trust's AGYS Position: Q2 2026 in Review

Glenmede Trust reduced its Agilysys (AGYS) stake by 36% in Q2 2026, selling an estimated $154K and leaving 3,532 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Glenmede Trust first reported a position in AGYS in Q3 2019 and has held it in 11 quarters since. The position peaked at $636K in Q4 2025. 290 funds tracked by Wall St. Rank hold AGYS as of Q2 2026.

  • Glenmede Trust held 3,532 shares of Agilysys worth $369K as of Q2 2026.
  • Glenmede Trust sold 1,986 Agilysys shares in Q2 2026, an estimated $154K.
  • Agilysys made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1093 holding.
  • Glenmede Trust first reported a position in Agilysys in Q3 2019 and has held it in 11 quarters since.
  • Glenmede Trust's Agilysys position peaked at $636K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Agilysys as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.